Phase 4
N=100
RCT Superior Hypogastric Block During LH
Hysterectomy
Bottom Line
View on ClinicalTrials.gov: NCT03283436 ↗Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcome: Primary: Postoperative Pain Scores — 3.9; 4.7 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Bupivacaine Hydrochloride 0.25% Injection Solution (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Jon I. Einarsson
- Primary completion
- Feb 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Postoperative Pain Scores |
5; 6; 6.3; 5.6; 5.5; 5 | — |
| SECONDARY Postoperative Opioid Use |
5; 10.2; 2.5; 5; 0; 2.5 | — |
| SECONDARY Postoperative Pain Scores |
5; 6; 6.3; 5.6; 5.5; 5 | — |
Summary
The goal of this study is to assess the efficacy of a superior hypogastric plexus block (SHPB) for pain relief following a laparoscopic hysterectomy.
Eligibility Criteria
Inclusion Criteria
- Over age 18
- English Speaking
- Able to provide informed consent
- Undergoing laparoscopic hysterectomy for benign indications
Exclusion Criteria
- Planned laparotomy incision
- Planned procedure that requires dissection of the presacral space
- Allergy to block medication (s)
- Known or suspected malignancy
- Non-English speaker
Data sourced from ClinicalTrials.gov (NCT03283436). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.